alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › synaptotoxic

synaptotoxic

2 studies tagged synaptotoxic, dated 2011-02-12 to 2012-02-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific 2012-02-01
  2. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices 2011-02-12

Studies

2 studies carry this tag.

Date range

2011 to 2012

Top journals

  • Neuropharmacology 1
  • The Journal of neuroscience : the official journal of the Society for Neuroscience 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 2012-02-01 Treatments

    Several anti-amyloid β (Aβ) antibodies are under evaluation for the treatment of Alzheimer's disease (AD).

  2. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuropharmacology 2011-02-12 Treatments

    Ample evidence suggests that impairment in glutamatergic signalling is associated with AD pathology.

All topic tags with their study counts